Reuters logo
3 个月前
BRIEF-Kura Oncology granted U.S. patent for clinical-stage ERK inhibitor
2017年4月19日 / 中午11点41分 / 3 个月前

BRIEF-Kura Oncology granted U.S. patent for clinical-stage ERK inhibitor

1 分钟阅读

April 19 (Reuters) - Kura Oncology Inc:

* Kura Oncology granted U.S. patent for clinical-stage ERK inhibitor, KO-947 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below